Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab.
Weber J, Gibney G, Kudchadkar R, Yu B, Cheng P, Martinez AJ, Kroeger J, Richards A, McCormick L, Moberg V, Cronin H, Zhao X, Schell M, Chen YA.
Weber J, et al.
Cancer Immunol Res. 2016 Apr;4(4):345-53. doi: 10.1158/2326-6066.CIR-15-0193. Epub 2016 Feb 12.
Cancer Immunol Res. 2016.
PMID: 26873574
Free PMC article.
Clinical Trial.